Chris Larsen, the Chairman of Ripple , has made a notable donation of 1.7 million XRP tokens—valued at approximately $1 million—to support Vice President Kamala Harris's 2024 campaign. The ...
Mt. Gox, the former Bitcoin exchange that shut down in 2014, has delayed its repayment deadline by a year, leading to a rise in Bitcoin's price. The cryptocurrency climbed above $62,200, gaining ...
James Howells, an IT engineer from Newport, is suing Newport City Council for approximately $647 million in damages after the council refused to allow him to search for a hard drive containing 8,000 ...
The U.S. Food and Drug Administration (FDA) has granted approval for Pfizer’s latest treatment, Hympavzi, designed to manage the two primary forms of hemophilia, the pharmaceutical company announced ...
Elon Musk’s much-anticipated unveiling of Tesla's (NASDAQ:TSLA) self-driving taxi prototypes failed to meet the expectations of many investors, leaving them questioning how the carmaker can deliver on ...
JPMorgan Chase & Co. , a leader in global finance, has reported its earnings for the third quarter of 2024, with mixed results highlighting both growth and minor setbacks. The bank announced a net ...
Robotic technology powerhouse FBR (ASX:FBR) has constructed the walls of the first home in its US Demonstration Program, partnering with CRH Ventures. The milestone marks the first international ...
The U.S. Securities and Exchange Commission (SEC) has filed fraud charges against multiple market makers and individuals, accusing them of manipulating the trading of various crypto assets. These ...
Speakers at the Bitcoin Amsterdam 2024 conference discussed the far-reaching consequences of flawed academic research on Bitcoin , particularly how it misleads media coverage and results in misguided ...
Spot Bitcoin exchange-traded funds (ETFs) in the United States recorded a net inflow of $253.6 million on October 11, marking the end of three consecutive days of outflows. This surge was led by the ...
Denali Therapeutics (NASDAQ:DNLI) announced today that its strategic partner, Sanofi (NASDAQ:SNY), has decided to discontinue the K2 Phase 2 clinical study evaluating oditrasertib (SAR443820/DNL788) ...
CattleProof, a Wyoming-based company, has made history by becoming the first firm to receive the United States Department of Agriculture (USDA) approval for its blockchain-based Process Verified ...